Latest Monoclonal B-cell lymphocytosis Stories
Health Canada approves GAZYVA((TM)) (obinutuzumab), a medicine that harnesses the body's immune system to kill cancer cells, for patients with chronic lymphocytic leukemia (or CLL)
LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
A new study has discovered how resistance develops in patients taking ibrutinib, a new and highly effective drug for the treatment of chronic lymphocytic leukemia (CLL).
TG02 also shown to be equally active in CLL cells from patients prior to and following twelve months of ibrutinib therapy. San Diego (PRWEB) May 28, 2014
Use of a twice-daily pill could turn a deadly blood cancer into a highly treatable disease.
A new analysis has found that among patients with chronic lymphocytic leukemia, African Americans more commonly present with advanced disease, and they tend to have shorter survival times than Caucasians despite receiving the same care.
- A volcanic mudflow.